Back
Haemonetics Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer13.jpg)
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.
Buy
63
HAE
Haemonetics
Last Price:
84.95
Seasonality Move:
7.37%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer16.jpg)
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.Haemonetics Price Quote
$84.95
-0.01 (0.97%)
(Updated: July 6, 2024 at 5:45 AM ET)
Haemonetics Key Stats
Buy
63
Haemonetics (HAE)
is a Buy
Day range:
$83.86 - $85.02
52-week range:
$70.74 - $97.97
Dividend yield:
0%
P/E ratio:
37.10
P/S ratio:
3.34
P/B ratio:
4.51%
Volume:
320.4K
Avg. volume:
761.2K
1-year change:
1.23%
Market cap:
$4.3B
Revenue:
$1.3B
EPS:
$2.29
How Much Does Haemonetics Make?
-
How Much Are Haemonetics's Sales Annually?
HAE Revenues are $1.3B -
How Much Profit Does Haemonetics's Make A Year?
HAE net income is $117.6M
Is Haemonetics Growing As A Company?
-
What Is Haemonetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.13% -
What Is Haemonetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.3%
Haemonetics Stock Price Performance
-
Did Haemonetics Stock Go Up Last Month?
Haemonetics share price went down by -4.38% last month -
Did HAE's Share Price Rise Over The Last Year?
HAE share price rose by 1.23% over the past 1 year
What Is Haemonetics 52-Week High & Low?
-
What Is Haemonetics’s 52-Week High Share Price?
Haemonetics has traded as high as $97.97 over the past 52 weeks -
What Is Haemonetics’s 52-Week Low Share Price?
Haemonetics has traded as low as $70.74 over the past 52 weeks
Haemonetics Price To Free Cash Flow
-
Is Haemonetics Stock Overvalued?
Haemonetics is trading at a price to free cash flow ratio of 37.82 -
Is Haemonetics Stock Undervalued?
Haemonetics EV to Free Cash Flow ratio is 42.94 -
What Is Haemonetics’s Price Earnings Growth Ratio?
HAE PEG ratio is 13.79 -
Is Haemonetics Trading At A Premium To Earnings?
Haemonetics EV to EBIT ratio is 30.07
Is It Risky To Buy Haemonetics?
-
How Much Debt Does Haemonetics Have?
Total long term debt quarterly is $807.8M -
How Much Cash Does Haemonetics Have?
Cash and short term investments quarterly total is $178.8M -
What Is Haemonetics’s Book Value Per Share?
Book value per share is 18.90
Is Haemonetics Cash Flow Positive?
-
What Is HAE Cash Flow From Operations?
Cash flow from operations (TTM) is $181.8M -
What Is Haemonetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $38.2M -
What Is Haemonetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$322.4M
Haemonetics Return On Invested Capital
-
Is Management Doing A Good Job?
HAE return on invested capital is 6.96% -
What Is Haemonetics Return On Assets?
ROA measures how assets are converting to revenues and is 5.7% -
What Is HAE Return On Equity?
ROE is a measure of profitability and is 13.12%
Haemonetics Earnings Date & Stock Price
-
What Is Haemonetics's Stock Price Today?
A single share of HAE can be purchased today for 84.96 -
What Is Haemonetics’s Stock Symbol?
Haemonetics trades on the nyse under the ticker symbol: HAE -
When Is Haemonetics’s Next Earnings Date?
The next quarterly earnings date for Haemonetics is scheduled on August 8, 2024 -
When Is HAE's next ex-dividend date?
Haemonetics's next ex-dividend date is July 7, 2024 -
How To Buy Haemonetics Stock?
You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Haemonetics Competitors
-
Who Are Haemonetics's Competitors?
Below is a list of companies who compete with Haemonetics or are related in some way:
Haemonetics Dividend Yield
Data Unavailable
Haemonetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -29.83% | 0.92% |
Revenue: | 12.77% | 4.2% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 113.50 |
Upside from Last Price: | 33.59% |